Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (21)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Clinical prediction rules for adverse evolution in patients with COVID-19 by the Omicron variant

    International Journal of Medical Informatics, Vol. 173

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques

    PLoS ONE, Vol. 18, Núm. 4 April

  5. Impact of Prior SARS-CoV-2 Infection and Vaccination on COVID-19 Infection Among Nursing Home Residents

    Journal of the American Medical Directors Association

  6. Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia

    Science of the Total Environment, Vol. 894

  7. Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents

    Aging Clinical and Experimental Research, Vol. 35, Núm. 8, pp. 1771-1778

  8. Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia

    Infection, Vol. 51, Núm. 5, pp. 1319-1327

  9. Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections

    Journal of Laboratory and Precision Medicine, Vol. 8

  10. Prior SARS-COV-2 infection, vaccination, COVID-19 hospital admission and mortality amongst nursing home residents: comment

    Aging Clinical and Experimental Research

  11. Short- and long-term prognosis of patients with community-acquired Legionella or pneumococcal pneumonia diagnosed by urinary antigen testing

    International Journal of Infectious Diseases, Vol. 134, pp. 106-113

2022

  1. Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)

    Scientific Reports

  2. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences

    Infection, Vol. 50, Núm. 1, pp. 179-189

  3. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  4. Diagnostic potential of leukocyte differential and cell population data in prediction of COVID-19 among related viral and bacterial infections at Emergency Department

    Clinical Chemistry and Laboratory Medicine

  5. Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia

    Journal of Infection, Vol. 85, Núm. 6, pp. 644-651

  6. Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 58, Núm. 12, pp. 802-808

2021

  1. Complete blood counts and cell population data from Sysmex XN analyser in the detection of SARS-CoV-2 infection

    Clinical Chemistry and Laboratory Medicine

  2. Leukocyte differential and reactive lymphocyte counts from Sysmex XN analyzer in the evaluation of SARS-CoV-2 infection

    Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 81, Núm. 5, pp. 394-400

  3. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477